some figures, page-14

Fed, not sure how your ref to the Merck drug affects the logic of your pre-selling 16/3 post:

i fink 350-400million incl latest placement. Its a working drug. and a necessary drug with a big market and what appears to be little in the way of competition.

But in fairness, as soon as you sold, you did change direction with:

22/3: trial results were good supertramp. just worried about the competition.

Then of course, there was your question today (post-sell) urging Damien to sell, with the helpful point of...

Damien what is AVX going to do for two years?

Maybe refer to your pre-sell post on 20/3:

'I believe theres more irons to the fire to AVX, antibacterial should do well.'

Still, you have provided me and, I'm sure, others with plenty of amusement as I go over your back-flipping posts.